Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Thermoforming sheet loading apparatus and method
Transmitter having a programmable amplifier operating class
Method and structure for image local contrast enhancement
Synthesizing VHDL multiple wait FSMS into RT level FSMS by preprocessing
System and method for conditionally sending a request for data to a home node
Method and apparatus for generating images using a color field sequential display
Breathing mask
  Randomly Featured Patents
Deployable heat shield and deceleration structure for spacecraft
Optically corrected shield for safety helmet
Production method of .alpha.-SiC wafer
Sheet processing apparatus
Display device with rail support
Method for the calibration of an oxygen sensing unit and calibration agent therefor
X-ray computerized tomography apparatus
Dual push-pull induction heating drive circuit
Electrosurgical generator method
Purification of carbon nanotubes using agarose column and density gradient ultracentrifugation